Alzheimer's Disease Markers in Aged ApoE-PON1 Deficient Mice

被引:16
|
作者
Narasimhulu, Chandrakala Aluganti [1 ]
Mitra, Connie [1 ]
Bhardwaj, Deepshikha [1 ]
Burge, Kathryn Young [1 ]
Parthasarathy, Sampath [1 ]
机构
[1] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA
关键词
Atherosclerosis; blood-brain barrier; neurological markers; PON1; APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; MOUSE MODEL; ATHEROSCLEROSIS; POLYMORPHISMS; PATHOGENESIS; ASSOCIATION; MACROPHAGES; PLAQUE; BRAIN;
D O I
10.3233/JAD-180883
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) is a neurodegenerative disorder associated with aging. Cardiovascular risk factors like hypertension and atherosclerosis increase the risk for AD. Polymorphic alleles of apolipoprotein E (ApoE) are one of the main genetic determinants of AD. Objective: Mice, double-knockout (DKO) for ApoE (major cholesterol carrier in brain) and PON1 (paroxonase1, reduces oxidative stress), showed severe age-dependent atherosclerosis of the arteries carrying blood to the brain even on normal diet. This prompted us to investigate the possibility of an AD pathology resulting from the deficiency of ApoE and the induction of oxidative stress. Methods: Atherosclerotic lesions were quantified by ImageJ. The brain hippocampus of young and old ApoE-PON1 DKO mice and control mice were harvested. RT-PCR analysis was performed for mRNA levels of AD specific markers. Blood levels of S100 calcium-binding protein B (S100B) protein were measured by ELISA. H&E as well as immunostaining was performed to detect amyloid-beta (A beta) plaques and neurofibrillary tangles (NFTs) in brain tissues. Evans blue dye was used to evaluate the vascular permeability and blood-brain barrier (BBB) dysfunction. Results: Results showed that the older DKO mice had severe carotid atherosclerosis, increased mRNA levels of AD markers in brain tissue, and elevated levels of serum S100B protein. Immunological staining confirmed the characteristics of AD. Ex-vivo imaging showed higher levels of Evans blue dye in the ApoE-PON1 DKO mice brain tissues, pointing toward impaired vasculature. Conclusion: Aged ApoE-PON1 DKO mice displaying AD specific markers along with A beta plaques, NFTs, and disrupted BBB suggests the animals are suffering from AD.
引用
收藏
页码:1353 / 1365
页数:13
相关论文
共 50 条
  • [41] Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy
    Sakai, Kenji
    Boche, Delphine
    Carare, Roxana
    Johnston, David
    Holmes, Clive
    Love, Seth
    Nicoll, James A. R.
    ACTA NEUROPATHOLOGICA, 2014, 128 (06) : 777 - 789
  • [42] PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles
    Trentini, Alessandro
    Rosta, Valentina
    Riccetti, Raffaella
    Mola, Gianmarco
    Galletti, Riccardo
    Pinotti, Marco
    Senia, Vincenza
    Zuliani, Giovanni
    Cervellati, Carlo
    ANTIOXIDANTS, 2024, 13 (10)
  • [43] APOE effects on regional tau in preclinical Alzheimer's disease
    Young, Christina B.
    Johns, Emily
    Kennedy, Gabriel
    Belloy, Michael E.
    Insel, Philip S.
    Greicius, Michael D.
    Sperling, Reisa A.
    Johnson, Keith A.
    Poston, Kathleen L.
    Mormino, Elizabeth C.
    MOLECULAR NEURODEGENERATION, 2023, 18 (01)
  • [44] Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE
    Zhang, Xin
    Yuan, Tian
    Chen, Xuhui
    Liu, Xuebo
    Hu, Jun
    Liu, Zhigang
    PROGRESS IN LIPID RESEARCH, 2024, 93
  • [45] APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
    Michaelson, Daniel M.
    ALZHEIMERS & DEMENTIA, 2014, 10 (06) : 861 - 868
  • [46] ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease
    Chen, Wei
    Jin, Fengzhong
    Cao, Guihua
    Mei, Rong
    Wang, Yayun
    Long, Pan
    Wang, Xiaoming
    Ge, Wei
    CURRENT DRUG TARGETS, 2018, 19 (09) : 1038 - 1044
  • [47] S-Nitrosylation of ApoE in Alzheimer's Disease
    Abrams, Alexander J.
    Farooq, Amjad
    Wang, Gaofeng
    BIOCHEMISTRY, 2011, 50 (17) : 3405 - 3407
  • [48] The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer's Disease: Exploring Interactions With Sex
    Liu, Ying
    Song, Jing-Hui
    Xu, Wei
    Hou, Xiao-He
    Li, Jie-Qiong
    Yu, Jin-Tai
    Tan, Lan
    Chi, Song
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [49] Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease
    Shinohara, Mitsuru
    Murray, Melissa E.
    Frank, Ryan D.
    Shinohara, Motoko
    DeTure, Michael
    Yamazaki, Yu
    Tachibana, Masaya
    Atagi, Yuka
    Davis, Mary D.
    Liu, Chia-Chen
    Zhao, Na
    Painter, Meghan M.
    Petersen, Ronald C.
    Fryer, John D.
    Crook, Julia E.
    Dickson, Dennis W.
    Bu, Guojun
    Kanekiyo, Takahisa
    ACTA NEUROPATHOLOGICA, 2016, 132 (02) : 225 - 234
  • [50] APOE and metabolic dysfunction in Alzheimer's disease
    Johnson, Lance A.
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 131 - 151